Study in a Sentence: A new multi-component, transformer-based, open-source AI model, Boltz-2, predicts protein–drug binding ...

Meeting Completion Marks Major Step Toward Phase 3 AD04 Trial Launch Strategic Partnership Discussions Expected Following the ...

Simulations Plus, Inc. (NASDAQ:SLP) is one of the top 10 medical AI companies to buy according to analysts. On July 29, the ...

Certara, Inc., a global leader in biosimulation, today announced that the European Medicines Agency (EMA) has formally qualified the Simcyp® Simulator for use in regulatory submissions across the EU.

A professor at the Indiana Univesity Luddy School of Informatics, Computing and Engineering has co-authored a paper ...

An international team led by Einstein Professor Cecilia Clementi in the Department of Physics at Freie Universität Berlin introduces a breakthrough in protein simulation.

Insiders at the Food and Drug Administration are ringing alarm bells over the agency's use of an AI to fast-track drug ...

Researchers from the Cancer Genetics and Epigenetics group at IGTP have published a study in Scientific Reports presenting a ...

Simulations Plus, Inc. (Nasdaq: SLP) ("Simulations Plus"), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications ...

The Commonwealth Bank of Australia made headlines when it announced last week it would cut 45 call centre jobs, thanks to the ...

Researchers have developed a program that simulates human and animal cell behavior, creating digital models of tissues and ...

Co-authors: Roger Hancock, CEO of Recall InfoLink, and Gillian Kelleher, president and CEO of Kelleher Consultants LLC. -- OPINION -- On July 9, the FDA ...